CAD 0.04
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 54.1 Thousand CAD | -44.39% |
2022 | 927.54 Thousand CAD | -8.81% |
2021 | 1.01 Million CAD | -37.84% |
2020 | 1.63 Million CAD | 43.15% |
2019 | 1.14 Million CAD | 130.84% |
2018 | 495.2 Thousand CAD | 678.17% |
2017 | 63.63 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 96.64 Thousand CAD | -1.65% |
2024 Q1 | 98.26 Thousand CAD | -36.05% |
2023 Q4 | 153.66 Thousand CAD | -6.11% |
2023 Q2 | 253.03 Thousand CAD | 22.72% |
2023 FY | 515.82 Thousand CAD | -44.39% |
2023 Q1 | 206.18 Thousand CAD | -1.98% |
2023 Q3 | 163.66 Thousand CAD | -35.32% |
2022 Q2 | 244.65 Thousand CAD | 1.59% |
2022 Q4 | 210.34 Thousand CAD | -9.23% |
2022 FY | 927.54 Thousand CAD | -8.81% |
2022 Q1 | 240.81 Thousand CAD | -16.25% |
2022 Q3 | 231.72 Thousand CAD | -5.29% |
2021 FY | 1.01 Million CAD | -37.84% |
2021 Q2 | 268.51 Thousand CAD | 19.07% |
2021 Q4 | 287.54 Thousand CAD | 22.08% |
2021 Q3 | 235.54 Thousand CAD | -12.28% |
2021 Q1 | 225.51 Thousand CAD | -30.3% |
2020 Q4 | 323.55 Thousand CAD | -6.14% |
2020 Q3 | 344.73 Thousand CAD | -47.65% |
2020 Q2 | 658.49 Thousand CAD | 112.69% |
2020 FY | 1.63 Million CAD | 43.15% |
2020 Q1 | 309.6 Thousand CAD | -24.54% |
2019 Q2 | 260.15 Thousand CAD | 28.22% |
2019 Q1 | 202.9 Thousand CAD | 3.89% |
2019 FY | 1.14 Million CAD | 130.84% |
2019 Q4 | 410.3 Thousand CAD | 52.1% |
2019 Q3 | 269.75 Thousand CAD | 3.69% |
2018 Q2 | 134.43 Thousand CAD | 78.2% |
2018 Q3 | 90.01 Thousand CAD | -33.04% |
2018 FY | 495.2 Thousand CAD | 678.17% |
2018 Q4 | 195.3 Thousand CAD | 116.96% |
2018 Q1 | 75.44 Thousand CAD | 19.27% |
2017 Q4 | 63.25 Thousand CAD | 16458.9% |
2017 FY | 63.63 Thousand CAD | 0.0% |
2017 Q3 | 382.00 CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | 66.834% |
Ayurcann Holdings Corp. | 11.71 Million CAD | 99.538% |
Blueberries Medical Corp. | 84.22 Thousand CAD | 35.767% |
The BC Bud Corporation | 1.28 Million CAD | 95.783% |
BioNxt Solutions Inc. | 6.73 Million CAD | 99.197% |
CordovaCann Corp. | 3.86 Million CAD | 98.599% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | 98.737% |
Captor Capital Corp. | 16.28 Million CAD | 99.668% |
City View Green Holdings Inc. | 705.7 Thousand CAD | 92.334% |
1CM Inc. | 7.3 Million CAD | 99.26% |
Global Hemp Group Inc. | 551.7 Thousand CAD | 90.194% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 98.875% |
IM Cannabis Corp. | 22.63 Million CAD | 99.761% |
Lobe Sciences Ltd. | 4.13 Million CAD | 98.691% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | 86.207% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | 9.833% |
Nextleaf Solutions Ltd. | 1.76 Million CAD | 96.94% |
Pharmadrug Inc. | 1.33 Million CAD | 95.948% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | 95.856% |
RAMM Pharma Corp. | 7.48 Million CAD | 99.277% |
RIV Capital Inc. | 21.1 Million CAD | 99.744% |
Revive Therapeutics Ltd. | 3.28 Million CAD | 98.353% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | 99.857% |
SLANG Worldwide Inc. | 24.6 Million CAD | 99.78% |
1933 Industries Inc. | 5.12 Million CAD | 98.944% |
Red Light Holland Corp. | 2.02 Million CAD | 97.322% |
Top Strike Resources Corp. | 3.63 Million CAD | 98.51% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 117.541% |
Adastra Holdings Ltd. | 9.36 Million CAD | 99.422% |